During the past decade, Policlinico Citta' Di Pomezia S. Anna - U.O. Cardiologia-Utic conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Policlinico Citta' Di Pomezia S. Anna - U.O. Cardiologia-Utic" are "Atrial Fibrillation" (1 trials), "Chronic Ischemic Heart Disease" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Policlinico Citta' Di Pomezia S. Anna - U.O. Cardiologia-Utic" in a lesser frequency.

Most popular intervention types in "Policlinico Citta' Di Pomezia S. Anna - U.O. Cardiologia-Utic" are "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atrial Fibrillation" (1 trials) and "Data collection on Stable Ischemic heart disease" (1 trials). Other intervention names were less common.

The vast majority of trials in "Policlinico Citta' Di Pomezia S. Anna - U.O. Cardiologia-Utic" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Policlinico Citta' Di Pomezia S. Anna - U.O. Cardiologia-Utic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Policlinico Citta' Di Pomezia S. Anna - U.O. Cardiologia-Utic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Policlinico Citta' Di Pomezia S. Anna - U.O. Cardiologia-Utic, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".